ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2018 American Transplant Congress

    Delivery of Culturally-Competent Transplant Care among Hmong Kidney Transplant Recipients: Outcomes from a Single Institution

    M. Odegard,1 O. Serrano,1 K. Peterson,1 S. Mongin,2 D. Berglund,3 D. Vock,4 S. Chinnakotla,1 T. Dunn,1 E. Finger,1 R. Kandaswamy,1 T. Pruett,1 A. Matas.1

    1Division of Transplantation, Division of Surgery, University of Minnesota, Minneapolis, MN; 2Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN; 3Informatics Services for Research and Reporting, Fairview, University of Minnesota, Minneapolis, MN; 4Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.

    OBJECTIVE: Kidney transplantation (KT) entails delivery of complex, well-coordinated, multidisciplinary care. Cultural and linguistic discordance among transplant providers and patients can lead to healthcare disparities.…
  • 2018 American Transplant Congress

    Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study

    E. Bailly,1 G. Blancho,2 S. Ville,2 E. Morelon,3 J. Bamoulid,4 S. Caillard,5 V. Chatelet,6 P. Malvezzi,7 J. Tourret,8 V. Vuiblet,9 D. Anglicheau,10 D. Bertrand,11 P. Grimbert,12 F. Haidar,13 M. Hazzan,14 N. Kamar,15 P. Merville,16 C. Mousson,17 V. Pernin,18 C. Pouteil-Noble,19 R. Purgus,20 J. Sayegh,21 P. Westeel,22 M. Büchler.1

    1University Hospital, Tours, France; 2Institut de Transplantation-Urologie-Néphrologie, Nantes, France; 3University Hospital, Lyon Edouard Herriot, France; 4University Hospital, Besançon, France; 5University Hospital, Strasbourg, France; 6University Hospital, Caen, France; 7University Hospital, Grenoble, France; 8Pitié Salpêtrière Hospital, APHP, Paris, France; 9University Hospital, Reims, France; 10Necker Hospital, APHP, Paris, France; 11University Hospital, Rouen, France; 12Mondor Hospital, APHP, Paris, France; 13Territorial Hospital, Noumea, France; 14University Hospital, Lille, France; 15University Hospital, Toulouse, France; 16University Hospital, Bordeaux, France; 17University Hospital, Dijon, France; 18University Hospital, Montpellier, France; 19University Hospital, Lyon Sud, France; 20University Hospital, Marseille, France; 21University Hospital, Angers, France; 22University Hospital, Amiens, France.

    Background The place of rituximab in the treatment of acute antibody-mediated rejection (ABMR) is still controversial. The French multicenter double-blind, placebo-controlled RITUX ERAH study included…
  • 2018 American Transplant Congress

    Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients

    D. Florescu,1 M. Grimley,2 G. Papanicolaou,3 V. Prasad,4 E. Vainorius,5 G. Chittick,5 T. Brundage,5 G. Nichols.5

    1Univ Nebraska Med Center, Omaha; 2Cincinnati Children's Hosp Center, Cincinnati; 3Memorial-Sloan Kettering Cancer Center, New York; 4Pediatric BMT, Duke Univ Med Center, Durham, NC; 5Chimerix, Inc., Durham.

    Background: Adenovirus (AdV) infections cause significant morbidity and mortality in immunocompromised patients. Brincidofovir (BCV) is an investigational antiviral drug with high in vitro potency against…
  • 2018 American Transplant Congress

    Waitlist Outcomes and Access to Liver Transplantation for HIV+ Candidates

    A. Shaffer,1 A. Thomas,1 A. Massie,1 S. Gustafson,2 J. Snyder,2 B. Shelton,3 R. Reed,3 J. Locke,3 D. Segev,1,2 C. Durand.1

    1JHU, Baltimore; 2SRTR, Minneapolis; 3UAB, Birmingham.

    Liver disease is a leading cause of death for HIV+ individuals, and the number of HIV+ liver transplant recipients is increasing. However, since UNOS does…
  • 2018 American Transplant Congress

    Racial Disparities in Post-Liver Transplant Survival before and after Share 35 Implementation

    K. Ross,1 R. Lynch,2 R. Patzer.1,2

    1Department of Epidemiology, Rollins School of Public Health, Atlanta, GA; 2Emory Transplant Center, Atlanta, GA.

    Background: The Share 35 policy was intended to improve equity in access to liver transplantation by broadening regional sharing of livers for the sickest patients…
  • 2018 American Transplant Congress

    Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation

    T. Schachtner,1,2,3 N. Otto,1 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charite Campus Virchow Clinic, Berlin, Germany; 3Berlin Institute of Health (BIH), Charite and Max Delbrueck Center, Berlin, Germany.

    In 1999, the Eurotransplant Senior Program (ESP) was implemented and allocates kidneys from deceased-donors ≥65 years to kidney transplant recipients ≥65 years (ESP-KTRs). The ESP…
  • 2018 American Transplant Congress

    Hospital Readmission Patterns in the First Year after Kidney Transplantation: A Twelve-Year, Single-Center Experience

    M. Nguyen, C. Avila, J. Benedict, A. El-Hinnawi, A. Rajab, R. Pelletier, M. Henry, G. Bumgardner.

    Transplant Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

    Purpose: The majority of studies examining hospital readmissions (HR) after kidney transplantation (KT) focus on 30-day HR rates using multi-institutional data with non-uniform clinical protocols.…
  • 2018 American Transplant Congress

    Donor Bacteremia Does Not Impact Survival Following Heart Transplantation: A UNOS Registry Review

    S. Hirji, A. Woolley, M. Pelletier, P. Shekar, F. Yazdchi, H. Mallidi, S. Singh.

    Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA.

    Background: There is a reluctance to transplant organs from donors who are bacteremic due to concern for transmission of the infection to the recipient leading…
  • 2018 American Transplant Congress

    Livers from Diabetic Donors Can Safely Be Used in Donation after Circulatory Death Liver Transplantation

    I. Brüggenwirth,1 I. Vasiliauskaire,2 A. Westerkamp,1 W. Polak,2 A. Braat,3 R. Porte.1

    1Surgery, UMCG, Groningen, Netherlands; 2Surgery, Erasmus MC, Rotterdam, Netherlands; 3Surgery, LUMC, Leiden, Netherlands.

    Liver grafts from donors with a history of diabetes mellitus (DM) have been associated with reduced graft survival after liver transplantation. Transplantation centers are often…
  • 2018 American Transplant Congress

    Is KDPI Valid for Hepatitis C Aviremic Kidneys?

    L. Sibulesky,1 C. Kling,1 C. Blosser,2 C. Johnson,2 A. Limaye,2 R. Bakthavatsalam,1 N. Leca,2 J. Perkins.1

    1Surgery, University of Washington Medical Center, Seattle, WA; 2Medicine, University of Washington Medical Center, Seattle, WA.

    KDRI is an estimate of post-transplant kidney graft failure. It is based on ten donor factors that independently affect transplant outcomes, including HCV status from…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences